These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up. Carey D; Baker D; Petoumenos K; Chuah J; Rogers GD; Watson J; Cooper DA; Emery S; Carr A; HIV Med; 2009 Mar; 10(3):163-72. PubMed ID: 19245538 [TBL] [Abstract][Full Text] [Related]
26. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Guaraldi G; Orlando G; De Fazio D; De Lorenzi I; Rottino A; De Santis G; Pedone A; Spaggiari A; Baccarani A; Borghi V; Esposito R Antivir Ther; 2005; 10(6):753-9. PubMed ID: 16218175 [TBL] [Abstract][Full Text] [Related]
27. Autologous fat grafting and injectable dermal fillers for human immunodeficiency virus-associated facial lipodystrophy: a comparison of safety, efficacy, and long-term treatment outcomes. Shuck J; Iorio ML; Hung R; Davison SP Plast Reconstr Surg; 2013 Mar; 131(3):499-506. PubMed ID: 23142937 [TBL] [Abstract][Full Text] [Related]
33. Poly-l-lactic acid for correction of localized facial lipoatrophy in an otherwise healthy young woman. Burgess CM Dermatol Surg; 2009 May; 35(5):881-4. PubMed ID: 19389088 [No Abstract] [Full Text] [Related]
34. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. Butterwick K; Lowe NJ J Am Acad Dermatol; 2009 Aug; 61(2):281-93. PubMed ID: 19615539 [TBL] [Abstract][Full Text] [Related]
35. Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. Duracinsky M; Leclercq P; Herrmann S; Christen MO; Dolivo M; Goujard C; Chassany O BMC Infect Dis; 2014 Sep; 14():474. PubMed ID: 25178390 [TBL] [Abstract][Full Text] [Related]
36. Soft tissue augmentation using sculptra. Humble G; Mest D Facial Plast Surg; 2004 May; 20(2):157-63. PubMed ID: 15643584 [TBL] [Abstract][Full Text] [Related]
37. Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-L-lactic acid for nasolabial folds. Lowe P; Lowe NJ; Patnaik R J Cosmet Laser Ther; 2011 Apr; 13(2):87-94. PubMed ID: 21401382 [TBL] [Abstract][Full Text] [Related]
38. The face of HIV and AIDS: can we erase the stigma? Kavouni A; Catalan J; Brown S; Mandalia S; Barton SE AIDS Care; 2008 Apr; 20(4):485-7. PubMed ID: 18449827 [TBL] [Abstract][Full Text] [Related]
39. A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. Sapra S; Stewart JA; Mraud K; Schupp R Dermatol Surg; 2015 May; 41(5):587-94. PubMed ID: 25915626 [TBL] [Abstract][Full Text] [Related]
40. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients. Palm MD; Woodhall KE; Butterwick KJ; Goldman MP Dermatol Surg; 2010 Feb; 36(2):161-70. PubMed ID: 20039924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]